We are studying the molecular mechanisms that occur in the female reproductive system, particularly those related to polycystic ovary syndrome, uterine myomas, endometriosis, adenomyosis and fertility disorders.
In addition to understanding the biology of these processes, our research also aims to develop diagnostic tests and identify therapeutic targets for effective treatment.
We focus on the analysis of physiological processes in the studied cells and tissues. We conduct experiments to determine the role of steroid and protein hormone receptors in reproduction, the effect of steroid hormones on pathological processes within and outside the reproductive system, and the effect of hormones on the development of cancerous processes or disorders of the physiology of the female reproductive system.
We use both basic and state-of-the-art molecular biology techniques in our research. Thanks to our ongoing collaboration with the medical community and access to clinical research material, we can conduct genetic and molecular analyses to identify key biomarkers associated with fertility and reproductive tract pathologies.
By focusing on collaborations with clinical centres at home and abroad, we can contribute to the development of modern, more effective diagnostic methods for the early detection of potential health problems.
As a result, we can also improve therapeutic options in gynaecology and reproductive medicine, as well as contribute to improving the treatment of reproductive disorders and infertility. In the long term, such innovations can significantly increase accessibility to advanced therapies, which will affect the quality of life of patients and their families.
